The ACR created the Musculoskeletal Ultrasound Course for Rheumatologists with Interventional Cadaver Workshop—Intermediate specifically for rheumatologists who are using musculoskeletal ultrasound in their practice and are ready to expand their skills.
Search results for: Ultrasound
MUEs and Muscular Ultrasound Guidance: An Unlikely Story
Medically Unlikely Edits (MUEs) were launched on January 1, 2007 by the Centers for Medicare and Medicaid Services (CMS) to reduce the paid claims error rate for Medicare Part B claims. The function of MUEs is to detect and deny unlikely CMS claims for a Medicare patient on a single, 24-hour date of service on a prepayment basis. This is achieved by limiting the frequency of services provided by a physician or medical supply company.
Is Ultrasound Right For YOUR Office?
Growth of ultrasound for rheumatic diseases leads many to wonder how it might fit into their practice
New Musculoskeletal Ultrasound Course
The ACR is broadening its educational offerings in musculoskeletal ultrasound by holding its first stand-alone musculoskeletal ultrasound course for rheumatologists this August in Chicago. The same course will be offered prior to the 2010 ACR/ARHP Annual Scientific Meeting.
The Physical Exam Begins with a Handshake
During the height of the pandemic four years ago, I took every precaution to avoid, or at the very least, delay contracting COVID-19. I religiously wore a mask in all public settings, I washed my hands so frequently that my skin became dry and cracked, and I studiously maintained a six-foot distance from others. But…
Case Report: Complicated Presentation Eventually Explained by Rare Syndrome
Pachydermoperiostosis (PDP), also known as Touraine-Solente-Golé syndrome or primary hypertrophic osteoarthropathy, is a rare syndrome that can be inherited as autosomal dominant, autosomal recessive, or sporadically. This progressive disease primarily affects males, who tend to have more severe features than females. PDP usually occurs during adolescence, often starting around puberty.1 The main clinical features are…
A Delicate Balance: How to Avoid Overmedicalization in Rheumatology
Rheumatologist Rachelle Buchbinder, AO, MBBS (Hons), MSc, PhD, discusses reducing overdiagnosis, overtreatment, low-value care and waste in medicine.
Poly-Refractory Rheumatoid Arthritis: An Uncommon Subset of a Difficult-to-Treat Disease
Difficult-to-treat rheumatoid arthritis (RA) is defined as the failure of two or more classes of biologic or targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) to control active or progressive disease in patients with RA. Between 5 and 20% of patients with RA have difficult-to-treat RA.
New Ways to Think about Polymyalgia Rheumatica
As they usually are, the pediatrics are absolutely correct: A child is not just a little adult. The same can be said for the eldest among us: Senior citizens are more than just old adults; they have their own biopsychosocial considerations that we, as rheumatologists, must tend to. Among all the conditions that we find…
Polymyalgia Rheumatica: New Tricks for an Old Disease
Originally posted Feb. 13, 2023; reposted in conjunction with publication of the PMR supplement to the February 2024 issue of The Rheumatologist. PHILADELPHIA—Polymyalgia rheumatica (PMR) is a chronic inflammatory condition that almost exclusively affects individuals older than 50.1 First described in 1888, PMR has been a recognized rheumatic disease since at least 1957. Diagnosing the…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 42
- Next Page »